Article
Viral gene delivery vectors: the next generation medicines for immune-related diseases
15 May 2020
Abstract excerpt
Viruses have evolved to efficiently express their genes in host cells, which makes them ideally suited as gene delivery vectors for gene and immunotherapies. Replication competent (RC) viral vectors encoding foreign or self-proteins induce strong T-cell responses that can be used for the development of effective cancer treatments. Replication-defective (RD) viral vectors encoding self-proteins are non-immunogenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
